HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 281, Issue 50, 38730-38737, December 15, 2006

This Article Abstract Full Text (PDF) All Versions of this Article: 281/50/38730    most recent M605956200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rey, O. Articles by Rozengurt, E. Search for Related Content PubMed PubMed Citation Articles by Rey, O. Articles by Rozengurt, E. Social Bookmarking                      What's this?

Requirement of the TRPC1 Cation Channel in the Generation of Transient Ca²⁺ Oscillations by the Calcium-sensing Receptor^*

Osvaldo Rey¹, Steven H. Young, Romeo Papazyan, Mark S. Shapiro², and Enrique Rozengurt³

From the Unit of Signal Transduction and Gastrointestinal Cancer, Division of Digestive Diseases, Department of Medicine, CURE: Digestive Diseases Research Center, Jonsson Comprehensive Cancer Center and Molecular Biology Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095 and Department of Physiology, University of Texas Health Science Center, San Antonio, Texas 78229

Received for publication, June 21, 2006 , and in revised form, October 10, 2006.

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

 
The calcium-sensing receptor (CaR) is an allosteric protein that responds to extracellular Ca²⁺ ([Ca²⁺]_o) and aromatic amino acids with the production of different patterns of oscillations in intracellular Ca²⁺ concentration ([Ca²⁺]_i). An increase in [Ca²⁺]_o stimulates phospholipase C-mediated production of inositol 1,4,5-trisphosphate and causes sinusoidal oscillations in [Ca²⁺]_i. Conversely, aromatic amino acid-induced CaR activation does not stimulate phospholipase C but engages an unidentified signaling mechanism that promotes transient oscillations in [Ca²⁺]_i. We show here that the [Ca²⁺]_i oscillations stimulated by aromatic amino acids were selectively abolished by TRPC1 down-regulation using either a pool of small inhibitory RNAs (siRNAs) or two different individual siRNAs that targeted different coding regions of TRPC1. Furthermore, [Ca²⁺]_i oscillations stimulated by aromatic amino acids were also abolished by inhibition of TRPC1 function with an antibody that binds the pore region of the channel. We also show that aromatic amino acid-stimulated [Ca²⁺]_i oscillations can be prevented by protein kinase C (PKC) inhibitors or siRNA-mediated PKC down-regulation and impaired by either calmodulin antagonists or by the expression of a dominant-negative calmodulin mutant. We propose a model for the generation of CaR-mediated transient [Ca²⁺]_i oscillations that integrates its stimulation by aromatic amino acids with TRPC1 regulation by PKC and calmodulin.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

 
The extracellular calcium-sensing receptor (CaR),⁴ a member of the C family of G protein-coupled receptors, is an allosteric protein that plays a major physiological role in correcting changes in extracellular concentration of Ca²⁺ ([Ca²⁺]_o) by regulating parathyroid hormone secretion (1, 2). Inactivating and activating mutations of the CaR in humans (3) and genetic disruption of the CaR gene in mice (4) established that the CaR functions in the control of Ca²⁺ homeostasis. Interestingly, the CaR is also expressed in many other tissues, including the gastrointestinal tract, brain, pituitary, thyroid, skin, breast, pancreas, lung, bone, and heart (reviewed in Ref. 5), suggesting that this receptor plays additional, yet to be defined, physiological roles in the regulation of cell function. Indeed, recent evidence indicates that the CaR is involved in the control of intestinal fluid transport (6) and bone localization of hematopoietic stem cells (7) as well as the progression and spread of several cancers, including colorectal, breast, ovary, and parathyroid (8).

Recent studies of CaR activation in individual living cells have shown that the intracellular concentration of Ca²⁺ ([Ca²⁺]_i) oscillates upon stimulation of CaR by an elevation in [Ca²⁺]_o (9, 10). In addition to its role as a sensor of [Ca²⁺]_o, the CaR is also stimulated by aromatic amino acids (11) that, like [Ca²⁺]_o, induce striking and lasting CaR-mediated [Ca²⁺]_i oscillations (10). However, the patterns of [Ca²⁺]_i oscillations induced by aromatic amino acids and [Ca²⁺]_o, which bind to topographically separate sites in the CaR (12, 13), are different (10). Aromatic amino acid stimulation of the CaR induces repetitive, low frequency, [Ca²⁺]_i spikes that return to the baseline level, a pattern known as transient oscillations. In contrast, [Ca²⁺]_o-elicited CaR activation produces high frequency sinus-oidal oscillations upon a raised plateau level of [Ca²⁺]_i. The amplitude, frequency, and duration of [Ca²⁺]_i oscillations are increasingly recognized to encode important information for a variety of biological processes, including gene expression and cell metabolism. However, the precise mechanisms responsible for the generation of different types of [Ca²⁺]_i oscillations remain incompletely understood (14-17).

Our previous studies indicated that activation of the CaR by increases in [Ca²⁺]_o promotes sinusoidal [Ca²⁺]_i oscillations through a phospholipase C/inositol 1,4,5-trisphosphate (Ins(1,4,5)P₃) cascade (18) and that protein kinase C (PKC) negatively regulates the frequency of [Ca²⁺]_o-induced [Ca²⁺]_i oscillations (19). Intriguingly, the transient [Ca²⁺]_i oscillations elicited by the CaR in response to amino acid stimulation do not involve the PLC/Ins(1,4,5)P₃ cascade but a different signaling pathway that requires the organization of the actin cytoskeleton and involves the heterotrimeric proteins of the G₁₂ subfamily, the small GTPase Rho, the scaffolding protein filamin-A, and the cytoplasmic tail of the CaR (18). Although the precise mechanism(s) that generates the transient [Ca²⁺]_i oscillations induced by the CaR has not been determined, we previously demonstrated that 2-aminoethoxydiphenyl borate, a modulator of cationic channels encoded by transient receptor potential (TRP) genes including TRPC1 (20, 21), abolished the transient, but not the sinusoidal, [Ca²⁺]_i oscillations mediated by the CaR (10). The most frequently proposed TRPC1 activation signal in mammals is calcium depletion from intracellular stores (reviewed in Refs. 22 and 23). In addition, other mechanisms that do not involve store depletion, such as receptor activation and plasma membrane stretch, can also lead to TRPC1 activation (24-26). Furthermore, a new concept of multiplicity of activation, including receptor- and store-operated modes of activation in the same cell, is emerging based on recent studies with the TRPC1-related TRPC5 and TRPC7 channels (27, 28). In the present study, we examined the hypothesis that TRPC1, a highly conserved and widely expressed channel that allows the flux of sodium and calcium across the plasma membrane (29), is an essential element in the generation of transient [Ca²⁺]_i oscillations in response to stimulation of the CaR by aromatic amino acids.

View larger version (90K): [in this window] [in a new window]   FIGURE 1. Expression and intracellular distribution of TRPC1 in HEK-CaR cells. Equivalent amounts of HEK-293 and HEK-CaR cells lysates were analyzed by Western blot using an anti-TRPC1 antibody as described under "Experimental Procedures" (top panel). Confocal microscopy and quantitative imaging analysis of TRPC1 and CaR were performed as described under "Experimental Procedures." Green fluorescence image of TRPC1 and red fluorescence image of CaR in HEK-CaR cells are displayed in panels A and B, respectively. C, colocalizations of TRPC1 and CaR fluorescence images are shown in white. D, simultaneous merging of total acquired green and red fluorescent images as well as calculated colocalized signals. Inset, scatter gram showing the distribution of green and red pixels as well as the colocalized ones (white) corresponding to panel D. Bar, 10 µm.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

Immunocytochemistry, Confocal Microscopy, and Quantitative Imaging Analysis—For immunocytochemistry, the cells were fixed in 10% buffered formalin phosphate for 15 min at 25 °C and then permeabilized with a solution of 0.4% Triton X-100-phosphate-buffered saline (PBS) for 5 min at 25 °C. After extensive PBS washing, the fixed cells were incubated for 18 h at 25 °C in blocking buffer (PBS-1% gelatin-0.05% Tween 20) and then stained at 25 °C for 60 min with the primary antibodies. Subsequently, the cells were washed with PBS-0.05% Tween 20 at 25 °C and stained at 25 °C for 60 min with Alexa Fluor-conjugated secondary antibodies diluted in blocking buffer and washed again with PBS-0.05% Tween 20. The samples were then mounted with a gelvatol-glycerol solution containing 2.5% 1,4-diazobicyclo-[2.2.2]octane.

Confocal microscopy was performed with a Zeiss PASCAL (Germany) laser-scanning microscope and a x63 Zeiss Plan-Apochromat oil immersion objective (numerical aperture, 1.45). Alexa 488 was excited with 488 nm light, and its emission (green) was selected through a 505/530 band pass filter. Alexa 546 was excited at 543 nm, and its emission (red) was detected through a 560 long pass filter. Images were collected in multitrack mode using the same image acquisition settings with LSM5 PASCAL imaging system software version 3.2 SP2 (Zeiss).

Quantitative imaging analysis to assess the colocalization of the CaR and TRPC1 was performed using Manders' overlap coefficient (31) as implemented by CoLocalizer Pro v. 1.4 software. The overlap coefficients generated by Manders' equation have values between 0 and 1; a value of 0 indicates that there is no colocalization, whereas a value of 1.0 means there is complete colocalization. A total of 10 fields from different dishes, each one containing at least 20 cells, were analyzed and the results obtained shown for a representative set of cells. Scatter gram shows the distribution of pixels in the image according to the selected pair of channels (green and red) with colocalized pixels in white.

Single Cell [Ca²⁺]_i Imaging—The cells were incubated in saline solution (Hanks Balanced Salt Solution; Invitrogen) without phenol red, containing 138 mM NaCl, 4 mM NaHCO₃, 0.3 mM Na₂HPO₄, 5 mM KCl, 0.3 mM KH₂PO₄, 1.5 mM CaCl₂, 0.5 mM MgCl₂, 0.4 mM MgSO₄, 5.6 mM D-glucose, 20 mM HEPES, pH 7.4, and 5 µM fura-2 AM for 45-60 min at 37 °C. The cells were then washed and placed in an experimental chamber, which was perfused with saline solution at 1.5 ml/min at 37 °C. The chamber, in turn, was placed on the stage of an inverted microscope connected to a digital imaging system. Ratios of images (340 nm excitation/380 nm excitation, emission filter 520 nm) were obtained at 1.5-s intervals (10). A region of interest covering 15 x 15 µm was defined over each cell, and the average ratio intensity over the region was converted to [Ca²⁺]_i using a calibration curve constructed with a series of calibrated buffered calcium solutions (Calcium Calibration Buffer Kit 2; Molecular Probes). A minimum of 100 cells/experiment, each experiment done in at least triplicate, was used to measure [Ca²⁺]_i.

View larger version (37K): [in this window] [in a new window]   FIGURE 2. Effect of TRPC1 down-regulation on CaR-mediated [Ca2+]i oscillations. HEK-CaR (Control) (A) or HEK-293 (B) cells were perfused with saline solution containing 5 mM L-Phe or 5 mM Ca2+ during the times indicated by the horizontal bars and the [Ca2+]i oscillations measured in individual cells as described under "Experimental Procedures." HEK-CaR cells were transfected with 50 nM non-targeted siRNA (N-t siRNA) (C), a pool of TRPC1 siRNA (pool TRPC1 siRNA) (D), or two individual siRNA targeting different TRPC1 coding regions (TRPC1 siRNA 1 and TRPC1 siRNA 2) (E and F) as described under "Experimental Procedures." After 48 h, the cultures were perfused with saline solution containing 5 mM L-Phe or 5 mM Ca2+ during the times indicated by the horizontal bars and the [Ca2+]i oscillations measured in individual cells as described under "Experimental Procedures." G, HEK-CaR cells transfected with the indicated amounts of non-targeted or pool TRPC1 siRNA that responded to 5 mM L-Phe stimulation 48 h post-transfection. A minimum of 100 cells/experiment, done in at least triplicate, was used to measured [Ca2+]i. Western blot analysis (H) and quantification (I) of TRPC1, -tubulin, and actin expression in non-stimulated HEK-CaR cells transfected with 50 nM of the indicated siRNA after 48 h. Results are representative of two independent experiments, and the values in panel I are normalized by -tubulin content. Bars, S.E.; N-t, non-targeted.

Western Blot Analysis—Samples of cell lysates were directly solubilized by boiling in SDS-PAGE sample buffer. Following SDS-4.5-15% PAGE, proteins were transferred to Immobilon-P membranes (Millipore Corp.) and blocked by overnight incubation with 5% nonfat dried milk in PBS-0.05% Tween 20 (PT). Membranes were then incubated at room temperature for 3 h with the primary antiserum diluted in PT. Immunoreactive bands were visualized using horseradish peroxidase-conjugated IgGs and enhanced chemiluminescence Western blotting ECL reagent (Amersham Biosciences).

Analysis of [Ca²⁺]_i Amplitude Response to [Ca²⁺]_o after TRPC1 Down-regulation—HEK-CaR cells transfected with non-targeted siRNA (50 nM), pooled TRPC1 siRNA (50 nM), TRPC1 siRNA1 (50 nM), or TRPC1 siRNA 2 (50 nM) were challenged 48 h post-transfection with 5 mM Ca²⁺ and the average amplitude of the [Ca²⁺]_i change determined in individual cells. We performed six separate experiments, examining 100cells/condition. In order to combine the data from the separate experiments, we normalized for each experiment the Ca²⁺ response by dividing the average amplitude from each of the TRPC1 siRNA-transfected cells by the ones transfected with non-targeted siRNA, e.g. pooled TRPC1 siRNA/non-targeted siRNA. The normalized responses from each of the six experiments were used to obtain a cumulative mean normalized response for each siRNA treatment.

View larger version (26K): [in this window] [in a new window]   FIGURE 3. Effect of TRPC1 activity inhibition on CaR-mediated [Ca2+]i oscillations. HEK-CaR cells loaded with fura-2 were untreated (Control) (A) or incubated for 30 min with 15 µg of anti-TRPC1 (B) or anti-Myc (D) antibodies before the [Ca2+]i oscillations were measured in individual cells as described under "Experimental Procedures." A minimum of 100 cells/experiment, done in at least triplicate, was used to measured [Ca2+]i. C, HEK-CaR cells incubated for 10 min with the indicated amount of anti-Myc or anti-TRPC1, preabsorbed or not during 1 h with 15 µg/ml with the immunizing peptide, that responded to 5 mM L-Phe stimulation. A minimum of 100 cells/experiment, done in at least triplicate, was used to measured [Ca2+]i. Bars, S.E.

	RESULTS AND DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

 
Expression and Intracellular Distribution of TRPC1 in HEK-293 Cells—HEK-293 stably expressing the human CaR, referred to as HEK-CaR, is a cell system widely used to study the regulation of the CaR (32). Initially, we verified that HEK-CaR express TRPC1, and subsequently we examined the intracellular distribution of this channel and the CaR. As shown in Fig. 1, top panel, HEK-CaR cells, as well as the parental HEK-293 cell line, express similar levels of TRPC1 as demonstrated by Western blot analysis. Immunocytochemistry and confocal microscopy of HEK-CaR cells co-stained with rabbit anti-TRPC1 and mouse monoclonal anti-CaR revealed TRPC1 immunoreactivity throughout the cytosol and a punctate distribution pattern in the plasma membrane (Fig. 1A), whereas CaR immunoreactivity was most prominent at the plasma membrane (Fig. 1B). No immunoreactivity was detected in HEK-CaR cells when the antibodies used against CaR or TRPC1 were preabsorbed with their corresponding immunizing peptides or in HEK-293 cells incubated with the anti-CaR antibody (data not shown). Quantitative imaging analysis of the distribution of TRPC1 and the CaR revealed that both proteins colocalized in discrete regions of the plasma membrane (Fig. 1C) with overlap coefficients of 0.014 ± 0.013 (mean ± S.E.) and 0.25 ± 0.013 for HEK-293 and HEK-CaR cells, respectively, as calculated by Manders' equation (31). The scatter gram (Fig. 1, inset) provides a qualitative analysis that shows the distribution of green and red pixels as well as the colocalized ones (white) displayed in panel D. The significant colocalization of CaR and TRPC1 is consistent with previous reports showing that these proteins localize to caveolin-rich plasma membrane domains (33, 34).

Once we established that HEK-CaR cells express TRPC1, we proceeded to examine the hypothesis that this cation channel mediates the CaR-mediated transient [Ca²⁺]_i oscillations. HEK-CaR cells were transfected with siRNA targeted against TRPC1 to examine changes in [Ca²⁺]_i after stimulation of the CaR as described under "Experimental Procedures."

siRNAs Targeting Different Regions of TRPC1 Prevent Transient [Ca²⁺]_i Oscillations in Response to L-Phe—As illustrated in Fig. 2A, intracellular Ca²⁺ imaging revealed that addition of 5 mM L-Phe to HEK-CaR cells stimulated striking transient [Ca²⁺]_i oscillations and that each [Ca²⁺]_i peak returned to base-line value. In contrast, an increase in the [Ca²⁺]_o from 1.5 to5mM induced a rapid elevation in [Ca²⁺]_i to a new base-line level followed by oscillatory [Ca²⁺]_i fluctuations. These sinusoidal [Ca²⁺]_i oscillations ceased when [Ca²⁺]_o was returned to 1.5 mM. Addition of L-Phe or [Ca²⁺]_o to wild-type HEK-293 cells did not induce any detectable change in [Ca²⁺]_i (Fig. 2B), demonstrating that the [Ca²⁺]_i oscillations observed in HEK-CaR in response to L-Phe and [Ca²⁺]_o stimulation were associated to the expression of the CaR. In some occasions, we observed in less than 3% of non-stimulated HEK-293 or HEK-CaR cells an upward drift in base-line [Ca²⁺]_i that never exceeds 5% of the initial measurement over 600 s of recording (data not shown).

Transfection of HEK-CaR cells with non-targeted siRNA did not affect the production of [Ca²⁺]_i oscillations induced by L-Phe or [Ca²⁺]_o (Fig. 2C). However, the transient, but not sinusoidal, [Ca²⁺]_i oscillations were selectively inhibited in HEK-CaR cells transfected with a pool of TRPC1 siRNA (Fig. 2D). Analysis of the ratio between the amplitude of the [Ca²⁺]_i oscillations in cells transfected with the different TRPC1 siR-NAs and non-targeted siRNA indicates that TRPC1 knock down did not significantly affect the CaR-mediated response to extracellular Ca²⁺ (pool TRPC1 siRNA/non-targeted siRNA = 1.00 + 0.16, mean ± S.E.; TRPC1 siRNA 1/non-targeted siRNA = 1.07 + 0.18; TRPC1 siRNA 2/non-targeted siRNA = 0.87 + 0.16; see "Experimental Procedures" for further details). To exclude the possibility that the inhibitory effect on L-Phe-induced [Ca²⁺]_i oscillations by the pool of TRPC1 siRNA was due to off-target effects (35), we performed additional experiments using two individual siRNA that targeted different coding regions of TRPC1. We found that the individual siRNAs prevented the production of [Ca²⁺]_i oscillations in response to L-Phe as effectively as the pool of TRPC1 siRNA (Fig. 2, E and F). [Ca²⁺]_i mobilization in response to carbachol stimulation, which acts through muscarinic receptors endogenously expressed in HEK-293 cells, was not affected by TRPC1 siRNA (data not shown).

View larger version (43K): [in this window] [in a new window]   FIGURE 4. Effect of PKC inhibition or down-regulation on CaR-mediated [Ca2+]i oscillations. HEK-CaR cells loaded with fura-2 were untreated (A) or treated for 1 h with Ro-31-7549 (10 µM) (B) or Ro-32-0432 (3 µM) (C) before the [Ca2+]i oscillations were measured in individual cells as described under "Experimental Procedures." HEK-CaR cells were transfected with 100 nM non-targeted siRNA (N-t siRNA) (D), 100 nM a pool of PKC siRNA (PKC siRNA) (E), or 100 nM a pool of PKC1 siRNA (PKC1 siRNA) (F) as described under "Experimental Procedures." After 48 h, the cultures were perfused with saline solution containing 5 mM L-Phe during the times indicated by the horizontal bars and the [Ca2+]i oscillations measured in individual cells. G, HEK-CaR cells transfected with the indicated amounts and siRNAs that responded to 5 mM L-Phe stimulation 48 h post-transfection. A minimum of 100 cells/experiment, done in at least triplicate, was used to measured [Ca2+]i. Western blot analysis (H) and quantification (I) of PKC, PKC1, and -tubulin expression in non-stimulated HEK-CaR cells transfected with 100 nM the indicated siRNAs after 48 h. Results are representative of two independent experiments; the values in panel I are normalized by -tubulin content. Bars, S.E.; N-t, non-targeted.

An Antibody Directed against the Pore Region of TRPC1 Blocks the Transient [Ca²⁺]_i Oscillations in Response to L-Phe—As an independent test of the hypothesis that TRPC1 mediates the transient [Ca²⁺]_i oscillations elicited by L-Phe-stimulation of the CaR, we used an antibody that interferes in vivo with the activity of this channel by binding the peptide sequence ⁵⁵⁷QLYDKGYTSKEQKDC⁵⁷¹ located in the pore region of the human TRPC1 (36). Exposure of HEK-CaR cells to the anti-TRPC1 antibody for 30 min inhibited L-Pheelicited transient [Ca²⁺]_i oscillations (Fig. 3B) in a dose-dependent manner (Fig. 3C). Importantly, the anti-TRPC1 antibody did not interfere with the [Ca²⁺]_o-stimulated sinusoidal [Ca²⁺]_i oscillations (Fig. 3B). The transient [Ca²⁺]_i oscillations inhibition mediated by the anti-TRPC1 antibody was abolished by preabsorbing the antibody during 1 h with 15 µg/ml of the immunizing peptide (Fig. 3C). No inhibition of sinusoidal or transient [Ca²⁺]_i oscillations was observed when the cells were exposed to an unrelated antibody, e.g. anti-Myc (Fig. 3D). These results further demonstrate that interference with TRPC1 function blocks the transient, but not the sinusoidal, [Ca²⁺]_i oscillations mediated by the CaR. Because TRPC1 can form homo- and heterotetramers (37, 38), further experiments are needed to determine whether other TRPCs also participate in the generation of [Ca²⁺]_i oscillations mediated by the CaR in response to aromatic amino acid stimulation.

View larger version (22K): [in this window] [in a new window]   FIGURE 5. Effect of CaM antagonists and DN-CaM on CaR-mediated [Ca2+]i oscillations. HEK-CaR cells loaded with fura-2 were untreated (A) or treated for 1 h with W7 (50 µM) (B) or W13 (15 µM) (C) before the [Ca2+]i oscillations were measured in individual cells in response to L-Phe stimulation. HEK-CaR were transfected with vectors encoding wild-type CaM (WT CaM) (D) or a CaM dominant-negative mutant (DN-CaM) (E) and the [Ca2+]i oscillations in response to L-Phe stimulation measured in individual cells 24 h post-transfection as described under "Experimental Procedures." A minimum of 100 cells/experiment, done in at least duplicate, was used to measured [Ca2+]i.

In agreement with our hypothesis, intracellular Ca²⁺ imaging revealed that the preferential PKC inhibitors Ro-31-7549 and Ro-32-0432 (41) abolished Ca²⁺ signaling elicited by L-Phe stimulation of the CaR (Fig. 4, B and C). Because the IC₅₀ of these compounds for the PKCs is not sufficient to unambiguously distinguish between the different isoforms (42), we used siRNA-mediated knock down to define the role of PKC in CaR-mediated [Ca²⁺]_i oscillations. HEK-CaR cells were transfected with a pool of PKC or PKC1 siRNA and the changes in [Ca²⁺]_i after L-Phe stimulation examined in single cells. As we previously demonstrated (see Fig. 2C), non-targeted siRNA did not affect the production of transient [Ca²⁺]_i oscillations (Fig. 4D). However, these oscillations were inhibited by the siRNA targeting PKC (Fig. 4E) but not PKC1 (Fig. 4F). This inhibition was dose dependent (Fig. 4G) and concurrent with a marked reduction of PKC expression.

To examine the role of CaM in the production of transient [Ca²⁺]_i oscillations, HEK-CaR cells were exposed to the CaM antagonists W7 (43) and W-13 (44). These agents did not prevent the rise in [Ca²⁺]_i elicited by L-Phe stimulation of the CaR but impaired the downward phase of the transient [Ca²⁺]_i oscillation, resulting in a sustained, non-oscillatory [Ca²⁺]_i increase (Fig. 5, B and C). To independently corroborate these results, we interfered with the function of endogenous CaM by expressing a DN-CaM form of this protein that has an alanine substitution in each of the four Ca²⁺-binding sites (D20A, D56A, D93A, D129A) (30). Transfection of HEK-CaR cells with a vector encoding wild-type CaM did not had any effect in the transient [Ca²⁺]_i oscillations mediated by L-Phe (Fig. 5D). In contrast, expression of the DN-CaM impaired the downward phase of the transient [Ca²⁺]_i oscillation in a similar fashion as we observed with the CaM antagonists (Fig. 5E).

Concluding Remarks—Based on the results presented here, as well as in our previous studies (18, 19), a model can be proposed to explain the mechanisms by which the CaR can function in two different modes, triggering high frequency sinusoidal oscillations in response to an increase in [Ca²⁺]_o or low frequency transient oscillations in response to aromatic amino acids in the presence of a threshold [Ca²⁺]_o (Fig. 6). In this model, the activation of the CaR by an elevation in [Ca²⁺]_o leads to phospholipase C-mediated hydrolysis of phosphatidylinositol (4,5)-bisphosphate to produce two second messengers, Ins(1,4,5)P₃ and diacylglycerol. Ins(1,4,5)P₃ binds to its intracellular receptor, a ligand-gated Ca²⁺ channel located in the endoplasmic reticulum membrane, and triggers the release of Ca²⁺ from internal stores. The rise in the concentration of free intracellular Ca²⁺ and diacylglycerol activates PKC. Activated PKC then phosphorylates the CaR, at Thr-888, providing the negative feedback needed to cause sinusoidal [Ca²⁺]_i oscillations.

The binding of aromatic amino acids to a topographically distinct site from the Ca²⁺ binding region (12) in the extracellular domain of the CaR engages, through its cytoplasmic tail, a multiprotein complex that includes Rho, filamin-A, and TRPC1. This interaction leads to TRPC1 channel opening and extracellular Ca²⁺ entry, which is further stimulated by PKC. In this regard, we previously reported that L-Phe stimulation of HEK-CaR promoted oscillatory translocations of PKC from the cytosol to the plasma membrane (18). Furthermore, recent reports indicate that the binding of Ca²⁺ to the C2 domain of PKC not only leads to membrane translocation but also promotes a conformational change that enables phosphatidylinositol (4,5)-bisphosphate to access a lysine-rich cluster located in a separated region of the C2 domain and activate the enzyme (45-47). Thus, it is reasonable to assume that the membrane-associated state of PKC is active, as suggested by our model. As [Ca²⁺]_i increases, activated (i.e. Ca²⁺ bound) CaM binds the C terminus of TRPC1 and inhibits its activity initiating the downward phase of the spike, a function impaired by CaM antagonists and the DN-CaM. The capacity of the CaR to couple to G_q/phospholipase C (18) or to TRPC1, as proposed in Fig. 6, provides a plausible explanation for the remarkable ability of this receptor to mediate sinusoidal and transient patterns of [Ca²⁺]_i oscillations in response to different agonists, i.e. Ca²⁺ and aromatic amino acids.

View larger version (20K): [in this window] [in a new window]   FIGURE 6. Model of CaR-mediated [Ca2+]i oscillations. The activation of the CaR by an elevation in [Ca2+]o leads to phospholipase C-mediated production of Ins(1,4,5)P3 and diacylglycerol. Ins(1,4,5)P3 binds to its intracellular receptor and triggers the release of Ca2+ from internal stores. The rise in the concentration of free intracellular Ca2+ and diacylglycerol activates PKC. Activated PKC then phosphorylates the CaR, at Thr-888, providing the negative feedback needed to cause sinusoidal [Ca2+]i oscillations. The binding of aromatic amino acids to the CaR engages a multiprotein complex that includes Rho, filamin-A, and TRPC1. This interaction leads to TRPC1 channel opening and extracellular Ca2+ entry, which is further stimulated by PKC.As[Ca2+]i increases, activated CaM binds the C terminus of TRPC1 and inhibits its activity.

	FOOTNOTES

 
^* This work was supported in part by National Institutes of Health Grants K01CA097956 (to O. R.) and DK 55003 and DK 56930 (to E. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

² Supported by National Institutes of Health Grant RO1 NS043394.

³ The Ronald S. Hirshberg Professor of Translational Pancreatic Cancer Research.

¹ To whom correspondence should be addressed: 900 Veteran Ave., Warren Hall Rm. 11-147, Dept. of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095-1786. Tel.: 310-794-5902; Fax: 310-267-2399; E-mail: orey{at}mednet.ucla.edu.

⁴ The abbreviations used are: CaR, Ca²⁺ sensing receptor; [Ca²⁺]_o, extracellular Ca²⁺; [Ca²⁺]_i, intracellular Ca²⁺; CaM, calmodulin; DN-CaM, dominant-negative CaM; Ins(1,4,5)P₃, inositol 1,4,5-trisphosphate; PKC, protein kinase C; siRNA, small inhibitory RNA; TRPC1, transient receptor potential channel 1; HEK, human embryonic kidney; PBS, phosphate-buffered saline.

	ACKNOWLEDGMENTS

 
We thank M. Doche for technical assistance. Support from the Morphology/Imaging Core of the CURE Center Grant 5 P30 DK41301 is gratefully acknowledged.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

 

1. Brown, E. M., Gamba, G., Riccardi, D., Lombardi, M., Butters, R., Kifor, O., Sun, A., Hediger, M. A., Lytton, J., and Hebert, S. C. (1993) Nature 366, 575-580[CrossRef][Medline] [Order article via Infotrieve]
2. Hebert, S. C., Brown, E. M., and Harris, H. W. (1997) J. Exp. Biol. 200, 295-302[Abstract]
3. Hendy, G. N., D'Souza-Li, L., Yang, B., Canaff, L., and Cole, D. E. (2000) Hum. Mutat. 16, 281-296[CrossRef][Medline] [Order article via Infotrieve]
4. Ho, C., Conner, D. A., Pollak, M. R., Ladd, D. J., Kifor, O., Warren, H. B., Brown, E. M., Seidman, J. G., and Seidman, C. E. (1995) Nat. Genet. 11, 389-394[CrossRef][Medline] [Order article via Infotrieve]
5. Quarles, L. D. (2003) Curr. Opin. Nephrol. Hypertens. 12, 349-355[CrossRef][Medline] [Order article via Infotrieve]
6. Geibel, J., Sritharan, K., Geibel, R., Geibel, P., Persing, J. S., Seeger, A., Roepke, T. K., Deichstetter, M., Prinz, C., Cheng, S. X., Martin, D., and Hebert, S. C. (2006) Proc. Natl. Acad. Sci. U. S. A. 130, 9390-9397
7. Adams, G. B., Chabner, K. T., Alley, I. R., Olson, D. P., Szczepiorkowski, Z. M., Poznansky, M. C., Kos, C. H., Pollak, M. R., Brown, E. M., and Scadden, D. T. (2006) Nature 439, 599-603[CrossRef][Medline] [Order article via Infotrieve]
8. Manning, A. T., O'Brien, N., and Kerin, M. J. (2006) Eur. J. Surg. Oncol. 32, 693-697[CrossRef][Medline] [Order article via Infotrieve]
9. Breitwieser, G. E., and Gama, L. (2001) Am. J. Physiol. 280, C1412-C1421
10. Young, S. H., and Rozengurt, E. (2002) Am. J. Physiol. 282, C1414-C1422
11. Conigrave, A. D., Quinn, S. J., and Brown, E. M. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 4814-4819[Abstract/Free Full Text]
12. Mun, H. C., Culverston, E. L., Franks, A. H., Collyer, C. A., Clifton-Bligh, R. J., and Conigrave, A. D. (2005) J. Biol. Chem. 280, 29067-29072[Abstract/Free Full Text]
13. Zhang, Z., Jiang, Y., Quinn, S. J., Krapcho, K., Nemeth, E. F., and Bai, M. (2002) J. Biol. Chem. 277, 33736-33741[Abstract/Free Full Text]
14. Putney, J. W., Jr., Broad, L. M., Braun, F. J., Lievremont, J. P., and Bird, G. S. (2001) J. Cell Sci. 114, 2223-2229
15. Shuttleworth, T. J., and Mignen, O. (2003) Biochem. Soc. Trans. 31, 916-919[Medline] [Order article via Infotrieve]
16. Galione, A., and Churchill, G. C. (2002) Cell Calcium 32, 343-354[CrossRef][Medline] [Order article via Infotrieve]
17. Berridge, M. J., Bootman, M. D., and Roderick, H. L. (2003) Nat. Rev. Mol. Cell. Biol. 4, 517-529[CrossRef][Medline] [Order article via Infotrieve]
18. Rey, O., Young, S. H., Yuan, J., Slice, L., and Rozengurt, E. (2005) J. Biol. Chem. 280, 22875-22882[Abstract/Free Full Text]
19. Young, S. H., Wu, S. V., and Rozengurt, E. (2002) J. Biol. Chem. 277, 46871-46876[Abstract/Free Full Text]
20. Xu, S. Z., Zeng, F., Boulay, G., Grimm, C., Harteneck, C., and Beech, D. J. (2005) Br. J. Pharmacol. 145, 405-414[CrossRef][Medline] [Order article via Infotrieve]
21. Delmas, P., Wanaverbecq, N., Abogadie, F. C., Mistry, M., and Brown, D. A. (2002) Neuron 34, 209-220[CrossRef][Medline] [Order article via Infotrieve]
22. Beech, D. J. (2005) Pfluegers Arch. Eur. J. Physiol. 451, 53-60[CrossRef][Medline] [Order article via Infotrieve]
23. Parekh, A. B., and Putney, J. W., Jr. (2005) Physiol. Rev. 85, 757-810[Abstract/Free Full Text]
24. Albert, A. P., and Large, W. A. (2002) J. Physiol. 544, 113-125[Abstract/Free Full Text]
25. Yoshida, T., Inoue, R., Morii, T., Takahashi, N., Yamamoto, S., Hara, Y., Tominaga, M., Shimizu, S., Sato, Y., and Mori, Y. (2006) Nat. Chem. Biol. 2, 596-607[CrossRef][Medline] [Order article via Infotrieve]
26. Maroto, R., Raso, A., Wood, T. G., Kurosky, A., Martinac, B., and Hamill, O. P. (2005) Nat. Cell Biol. 7, 179-185[CrossRef][Medline] [Order article via Infotrieve]
27. Lievremont, J. P., Bird, G. S., and Putney, J. W., Jr. (2004) Am. J. Physiol. 287, C1709-C1716
28. Zeng, F., Xu, S. Z., Jackson, P. K., McHugh, D., Kumar, B., Fountain, S. J., and Beech, D. J. (2004) J. Physiol. 559, 739-750[Abstract/Free Full Text]
29. Beech, D. J., Xu, S. Z., McHugh, D., and Flemming, R. (2003) Cell Calcium 33, 433-440[CrossRef][Medline] [Order article via Infotrieve]
30. Gamper, N., and Shapiro, M. S. (2003) J. Gen. Physiol. 122, 17-31[Abstract/Free Full Text]
31. Manders, E. M., Verbeek, F. J., and Aten, J. A. (1993) J. Microsc. (Oxf.) 169, 375-382
32. Brown, E. M., and MacLeod, R. J. (2001) Physiol. Rev. 81, 239-297[Abstract/Free Full Text]
33. Kifor, O., MacLeod, R. J., Diaz, R., Bai, M., Yamaguchi, T., Yao, T., Kifor, I., and Brown, E. M. (2001) Am. J. Physiol. 280, F291-F302
34. Lockwich, T. P., Liu, X., Singh, B. B., Jadlowiec, J., Weiland, S., and Ambudkar, I. S. (2000) J. Biol. Chem. 275, 11934-11942[Abstract/Free Full Text]
35. Jackson, A. L., and Linsley, P. S. (2004) Trends Genet. 20, 521-524[CrossRef][Medline] [Order article via Infotrieve]
36. Rosado, J. A., Brownlow, S. L., and Sage, S. O. (2002) J. Biol. Chem. 277, 42157-42163[Abstract/Free Full Text]
37. Hofmann, T., Schaefer, M., Schultz, G., and Gudermann, T. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 7461-7466[Abstract/Free Full Text]
38. Zagranichnaya, T. K., Wu, X., and Villereal, M. L. (2005) J. Biol. Chem. 280, 29559-29569[Abstract/Free Full Text]
39. Ahmmed, G. U., Mehta, D., Vogel, S., Holinstat, M., Paria, B. C., Tiruppathi, C., and Malik, A. B. (2004) J. Biol. Chem. 279, 20941-20949[Abstract/Free Full Text]
40. Singh, B. B., Liu, X., Tang, J., Zhu, M. X., and Ambudkar, I. S. (2002) Mol. Cell 9, 739-750[CrossRef][Medline] [Order article via Infotrieve]
41. Wilkinson, S. E., Parker, P. J., and Nixon, J. S. (1993) Biochem. J. 294, 335-337
42. Davies, S. P., Reddy, H., Caivano, M., and Cohen, P. (2000) Biochem. J. 351, 95-105[CrossRef][Medline] [Order article via Infotrieve]
43. Hidaka, H., Sasaki, Y., Tanaka, T., Endo, T., Ohno, S., Fujii, Y., and Nagata, T. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 4354-4357[Abstract/Free Full Text]
44. Tanaka, T., and Hidaka, H. (1980) J. Biol. Chem. 255, 11078-11080[Abstract/Free Full Text]
45. Corbalan-Garcia, S., Garcia-Garcia, J., Rodriguez-Alfaro, J. A., and Gomez-Fernandez, J. C. (2003) J. Biol. Chem. 278, 4972-4980[Abstract/Free Full Text]
46. Evans, J. H., Murray, D., Leslie, C. C., and Falke, J. J. (2006) Mol. Biol. Cell 17, 56-66[Abstract/Free Full Text]
47. Marin-Vicente, C., Gomez-Fernandez, J. C., and Corbalan-Garcia, S. (2005) Mol. Biol. Cell 16, 2848-2861[Abstract/Free Full Text]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				C. J. Justinich, N. Mak, I. Pacheco, D. Mulder, R. W. Wells, M. G. Blennerhassett, and R. J. MacLeod The extracellular calcium-sensing receptor (CaSR) on human esophagus and evidence of expression of the CaSR on the esophageal epithelial cell line (HET-1A) Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G120 - G129. [Abstract] [Full Text] [PDF]

				T. Murata, M. I. Lin, R. V. Stan, P. M. Bauer, J. Yu, and W. C. Sessa Genetic Evidence Supporting Caveolae Microdomain Regulation of Calcium Entry in Endothelial Cells J. Biol. Chem., June 1, 2007; 282(22): 16631 - 16643. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 281/50/38730    most recent M605956200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rey, O. Articles by Rozengurt, E. Search for Related Content PubMed PubMed Citation Articles by Rey, O. Articles by Rozengurt, E. Social Bookmarking                      What's this?